Effects of semaglutide on one-year medical costs among patients with obesity or overweight in US real world setting
{{output}}
Background: Patients with obesity or overweight are at increased risk for obesity-related complications (ORCs) including cardiovascular disease. Treatment with once-weekly (OW) semaglutide 2.4 mg has demonstrated clinical efficac... ...
